P3 Health Partners (PIII) Stock Sees Fair Value Lift After Strong EBITDA And Guidance
TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14
What's Going On With P3 Health Partners Stock Monday?
Top Midday Gainers
Lake Street Maintains Buy on P3 Health Partners, Raises Price Target to $14
P3 Health Partners Inc. Q1 2026 Earnings Call Summary
P3 Health Partners Inc (PIII) Q1 2026 Earnings Call Highlights: Surpassing Expectations and ...
P3 Health Partners (PIII) Stock Surges Over 42% After Hours: Here's Why
P3 Health Partners (NASDAQ:PIII) Delivers Major Turnaround, Beating Estimates and Raising Guidance
Full Transcript: P3 Health Partners Q1 2026 Earnings Call
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.700B to $1.500B-$1.650B vs $1.539B Est
P3 Health Partners Q1 EPS $(1.72) Beats $(3.28) Estimate, Sales $386.390M Miss $391.500M Estimate
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
P3 Health Partners Sees FY2026 Sales $1.500B-$1.700B vs $1.645B Est
P3 Health Partners Q4 EPS $(23.02) Misses $(9.46) Estimate, Sales $384.814M Beat $357.650M Estimate
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
How Recent Developments Are Reframing The P3 Health Partners (PIII) Investment Story
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.